The Role of Tumor/dendritic Cell Interactions in the Regulation of Anti-tumor Immunity: the Good, the Bad, and the Ugly

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2014 May 6

PMID 24795721

Citations 1

Authors

Kristian Michael Hargadon

Timothy N J Bullock

Affiliations

Soon will be listed here.

Citing Articles

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.

Saha C, Das M, Stephen-Victor E, Friboulet A, Bayry J, Kaveri S Molecules. 2016; 21(7).

PMID: 27428940 PMC: 6273690. DOI: 10.3390/molecules21070912.

References

Vasaturo A, Di Blasio S, Peeters D, de Koning C, de Vries J, Figdor C . Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go. Front Immunol. 2013; 4:417. PMC: 3847559. DOI: 10.3389/fimmu.2013.00417. View

Toubai T, Mathewson N, Reddy P . The role of dendritic cells in graft-versus-tumor effect. Front Immunol. 2014; 5:66. PMC: 3930914. DOI: 10.3389/fimmu.2014.00066. View

Schurch C, Riether C, Ochsenbein A . Dendritic cell-based immunotherapy for myeloid leukemias. Front Immunol. 2014; 4:496. PMC: 3876024. DOI: 10.3389/fimmu.2013.00496. View

Hosmalin A . Mining the resource of cross-presentation. Front Immunol. 2014; 5:62. PMC: 3936470. DOI: 10.3389/fimmu.2014.00062. View

Chmielewski M, Hombach A, Abken H . Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells. Front Immunol. 2013; 4:371. PMC: 3822734. DOI: 10.3389/fimmu.2013.00371. View

Dong H, Bullock T . Metabolic influences that regulate dendritic cell function in tumors. Front Immunol. 2014; 5:24. PMC: 3906600. DOI: 10.3389/fimmu.2014.00024. View

Schiavoni G, Mattei F, Gabriele L . Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response. Front Immunol. 2014; 4:483. PMC: 3872318. DOI: 10.3389/fimmu.2013.00483. View

Palombo F, Focaccetti C, Barnaba V . Therapeutic implications of immunogenic cell death in human cancer. Front Immunol. 2014; 4:503. PMC: 3880935. DOI: 10.3389/fimmu.2013.00503. View

van de Ven R, Lindenberg J, Oosterhoff D, de Gruijl T . Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression. Front Immunol. 2013; 4:403. PMC: 3839226. DOI: 10.3389/fimmu.2013.00403. View

10.

Hargadon K . Tumor-altered dendritic cell function: implications for anti-tumor immunity. Front Immunol. 2013; 4:192. PMC: 3708450. DOI: 10.3389/fimmu.2013.00192. View

11.

Gallois A, Bhardwaj N . Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment. Front Immunol. 2013; 4:436. PMC: 3857536. DOI: 10.3389/fimmu.2013.00436. View

12.

Dudek A, Martin S, Garg A, Agostinis P . Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity. Front Immunol. 2013; 4:438. PMC: 3858649. DOI: 10.3389/fimmu.2013.00438. View

13.

Zinkernagel R . On the Role of Dendritic Cells Versus Other Cells in Inducing Protective CD8+ T Cell Responses. Front Immunol. 2014; 5:30. PMC: 3918652. DOI: 10.3389/fimmu.2014.00030. View

14.

Seliger B, Massa C . The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape. Front Immunol. 2013; 4:419. PMC: 3845009. DOI: 10.3389/fimmu.2013.00419. View

15.

Steinman R, COHN Z . Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973; 137(5):1142-62. PMC: 2139237. DOI: 10.1084/jem.137.5.1142. View

16.

Tesone A, Svoronos N, Allegrezza M, Conejo-Garcia J . Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer. Front Immunol. 2013; 4:435. PMC: 3857526. DOI: 10.3389/fimmu.2013.00435. View

17.

Goyne H, Cannon M . Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer. Front Immunol. 2013; 4:382. PMC: 3831151. DOI: 10.3389/fimmu.2013.00382. View

18.

Ott P, Bhardwaj N . Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function. Front Immunol. 2013; 4:346. PMC: 3809567. DOI: 10.3389/fimmu.2013.00346. View